Old Web
English
Sign In
Acemap
>
Paper
>
Phase II trial of alimta plus gemzar administered every 21 days in patients with advanced pancreatic cancer
Phase II trial of alimta plus gemzar administered every 21 days in patients with advanced pancreatic cancer
2001
Hedy L. Kindler
D Strickland
W. Dugan
J. Visconti
J Liebman
Howard S. Hochster
Andrew Jacobs
J. Kugler
William J. John
Keywords:
Pancreatic cancer
Pathology
Oncology
Internal medicine
Medicine
General surgery
in patient
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
3
Citations
NaN
KQI
[]